Cardiac Side Effect of Rituximab
Indian Journal of Drugs in Dermatology · 2020-01 · 6 (1) · 49-52
DOI: 10.4103/ijdd.ijdd_64_19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Drugs in Dermatology, 2020-01. Verfasst von Vaibhav Bansidhar Patil und 2 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Rituximab is an anti-CD20 monoclonal antibody frequently used for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and anti-neutrophilic cytoplasmic antibody-associated vasculitis. In addition, rituximab has recently been increasingly used as an off-label treatment in a number of inflammatory and systemic autoimmune diseases. Its side effect profile includes infusion-related reactions and adverse cardiac effects such as arrhythmia and angina, particularly in patients with prior history of cardiovascular diseases. However, its detailed cardiotoxicity profile, effects on cardiac function, and its management are not well described in the literature. As the utility of rituximab expands, primary physicians, intensivist, dermatologist who use drug should be made of these serious cardiovascular adverse effect.
Zitieren
APA
Patil, V. B., Lunge, S. B., & Doshi, B. R. (2020). Cardiac Side Effect of Rituximab. Indian Journal of Drugs in Dermatology, 6(1), 49-52. https://doi.org/10.4103/ijdd.ijdd_64_19
Vancouver
Patil VB, Lunge SB, Doshi BR. Cardiac Side Effect of Rituximab. Indian Journal of Drugs in Dermatology. 2020;6(1):49-52. doi:10.4103/ijdd.ijdd_64_19
BibTeX
@article{Patil2020,
author = {Patil, Vaibhav Bansidhar and Lunge, Snehal Balvant and Doshi, Bhavana Ravindra},
title = {Cardiac Side Effect of Rituximab},
journal = {Indian Journal of Drugs in Dermatology},
year = {2020},
volume = {6},
number = {1},
pages = {49--52},
doi = {10.4103/ijdd.ijdd_64_19}
}
EUVIMED